NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$12.64 USD
+0.41 (3.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.64 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 15.09% |
ABR | 2.14 |
Earnings ESP
|
13.15% |
---|---|
Current Year | -1.78 |
Next Year | -1.84 |
EPS (TTM) | -1.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 131.54M | 134.00M | 540.58M | 582.23M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 135.00M | 136.30M | 546.90M | 596.90M |
Low Estimate | 129.43M | 131.50M | 529.21M | 572.05M |
Year ago Sales | 122.18M | 126.05M | 509.34M | 540.58M |
Year over Year Growth Est. | 7.66% | 6.31% | 6.13% | 7.71% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.44 | -1.78 | -1.84 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.37 | -0.40 | -1.75 | -1.79 |
High Estimate | -0.36 | -0.37 | -1.49 | -1.48 |
Low Estimate | -0.52 | -0.51 | -1.99 | -2.26 |
Year ago EPS | -0.50 | -0.54 | -1.95 | -1.78 |
Year over Year Growth Est. | 14.00% | 18.52% | 8.72% | -3.03% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.44 | -1.78 | -1.84 |
7 Days Ago | -0.43 | -0.44 | -1.78 | -1.84 |
30 Days Ago | -0.42 | -0.43 | -1.73 | -1.79 |
60 Days Ago | -0.44 | -0.44 | -1.74 | -1.81 |
90 Days Ago | -0.47 | -0.48 | -1.87 | -2.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.40 | -1.75 | -1.79 |
Zacks Consensus Estimate | -0.43 | -0.44 | -1.78 | -1.84 |
Earnings ESP | 13.15% | 8.68% | 1.80% | 2.78% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.46 | -0.54 | -0.50 | NA |
Estimate | -0.53 | -0.52 | -0.50 | -0.36 | NA |
Difference | 0.08 | 0.06 | -0.04 | -0.14 | -0.01 |
Surprise | 15.09% | 11.54% | -8.00% | -38.89% | -5.07% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more